Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06439706 · ClinicalTrials.gov registry record · NA
HPV Self-sampling for Underscreened Latinas
A NA study of Uterine Cervical Neoplasm, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT06439706 is a NA study of Uterine Cervical Neoplasm that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 108 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06439706, a NA study of Uterine Cervical Neoplasm, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn if women of Hispanic/Latina ethnicity are willing to self-collect a cervico-vaginal sample for HPV testing. The main question the study will answer is: • Does a brief educational intervention increase the feasibility and acceptability of HPV self-sampling among Hispanic/Latina women? The study team will compare whether including a brief educational intervention with a mailed HPV self-sampling kit is more acceptable than receiving a mailed HPV self-sampling kit alone. Participants will be asked to complete surveys at study entry (baseline) and then randomized to receive only the HPV self-sampling kit, or the kit plus a small group education that meets with a bilingual health educator. Participants will then be contacted about one-month later to complete a follow-up survey. The study team will also measure the number of participants in each group who self-collect a sample and mail it in for HPV testing.
Conditions Studied
Interventions
- BEHAVIORAL HPV Self-Sampling
- BEHAVIORAL Group Education
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2023-10-04 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06439706
The ClinicalTrials.gov registry entry for NCT06439706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Cervical Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which HPV Self-Sampling is the first listed.
NCT06439706 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06439706 about?
NCT06439706 is a clinical study titled "HPV Self-sampling for Underscreened Latinas". The goal of this study is to learn if women of Hispanic/Latina ethnicity are willing to self-collect a cervico-vaginal sample for HPV testing. The main question the study will answer is: • Does a brief educational intervention increase the feasibility and acceptability of HPV self-sampling among Hi...
What is the current status of trial NCT06439706?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2023-10-04. Estimated completion is 2024-09-30.
What conditions does trial NCT06439706 study?
This clinical trial studies the following conditions: Uterine Cervical Neoplasm.
What interventions are being tested in trial NCT06439706?
The interventions under investigation include: HPV Self-Sampling (BEHAVIORAL), Group Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT06439706?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06439706 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.